[
  {
    "drug_name": "Metformin",
    "generic_name": "metformin hydrochloride",
    "drug_class": "Biguanide",
    "indications": [
      "Type 2 diabetes mellitus",
      "Prediabetes",
      "Polycystic ovary syndrome"
    ],
    "mechanism_of_action": "Decreases hepatic glucose production, decreases intestinal absorption of glucose, and improves insulin sensitivity",
    "dosage": {
      "adult": "500-2000mg daily in divided doses",
      "pediatric": "Not recommended <10 years",
      "elderly": "Start with lower doses, monitor renal function"
    },
    "contraindications": [
      "Severe renal impairment (eGFR <30)",
      "Acute or chronic metabolic acidosis",
      "Hypersensitivity to metformin",
      "Severe liver disease"
    ],
    "side_effects": [
      "Nausea",
      "Vomiting",
      "Diarrhea",
      "Abdominal pain",
      "Metallic taste",
      "Lactic acidosis (rare but serious)"
    ],
    "drug_interactions": [
      {
        "drug": "Contrast media",
        "interaction": "Risk of lactic acidosis - hold 48 hours before and after",
        "severity": "major"
      },
      {
        "drug": "Alcohol",
        "interaction": "Increased risk of lactic acidosis",
        "severity": "moderate"
      },
      {
        "drug": "Cimetidine",
        "interaction": "Increased metformin levels",
        "severity": "moderate"
      }
    ],
    "monitoring": [
      "Renal function (eGFR)",
      "B12 levels (long-term use)",
      "Lactic acid levels if symptoms present"
    ],
    "pregnancy_category": "B",
    "breastfeeding": "Compatible",
    "sources": [
      {
        "type": "clinical_guideline",
        "title": "Metformin: A Review of Its Use in the Treatment of Type 2 Diabetes Mellitus",
        "journal": "Drugs",
        "year": 2019,
        "url": "https://link.springer.com/article/10.1007/s40265-019-01135-8"
      }
    ]
  },
  {
    "drug_name": "Warfarin",
    "generic_name": "warfarin sodium",
    "drug_class": "Vitamin K antagonist",
    "indications": [
      "Atrial fibrillation",
      "Deep vein thrombosis",
      "Pulmonary embolism",
      "Mechanical heart valves",
      "Stroke prevention"
    ],
    "mechanism_of_action": "Inhibits vitamin K epoxide reductase, preventing the synthesis of vitamin K-dependent clotting factors (II, VII, IX, X)",
    "dosage": {
      "adult": "2-10mg daily, adjusted based on INR",
      "pediatric": "0.1-0.2mg/kg daily",
      "elderly": "Lower initial doses, frequent monitoring"
    },
    "contraindications": [
      "Active bleeding",
      "Severe liver disease",
      "Pregnancy (except mechanical valves)",
      "Hypersensitivity to warfarin"
    ],
    "side_effects": [
      "Bleeding",
      "Bruising",
      "Hematuria",
      "Gastrointestinal bleeding",
      "Intracranial hemorrhage",
      "Skin necrosis (rare)"
    ],
    "drug_interactions": [
      {
        "drug": "Aspirin",
        "interaction": "Increased bleeding risk",
        "severity": "major"
      },
      {
        "drug": "NSAIDs",
        "interaction": "Increased bleeding risk",
        "severity": "major"
      },
      {
        "drug": "Antibiotics",
        "interaction": "Increased INR, bleeding risk",
        "severity": "major"
      },
      {
        "drug": "Green leafy vegetables",
        "interaction": "Decreased INR, reduced anticoagulation",
        "severity": "moderate"
      }
    ],
    "monitoring": [
      "INR (target 2-3 for most indications)",
      "Complete blood count",
      "Signs of bleeding"
    ],
    "pregnancy_category": "X",
    "breastfeeding": "Compatible with monitoring",
    "sources": [
      {
        "type": "clinical_guideline",
        "title": "Antithrombotic Therapy for Atrial Fibrillation: CHEST Guideline and Expert Panel Report",
        "journal": "Chest",
        "year": 2018,
        "url": "https://journal.chestnet.org/article/S0012-3692(18)30136-5/fulltext"
      }
    ]
  },
  {
    "drug_name": "Digoxin",
    "generic_name": "digoxin",
    "drug_class": "Cardiac glycoside",
    "indications": [
      "Heart failure with reduced ejection fraction",
      "Atrial fibrillation with rapid ventricular response"
    ],
    "mechanism_of_action": "Inhibits Na+/K+ ATPase, increasing intracellular calcium and myocardial contractility",
    "dosage": {
      "adult": "0.125-0.25mg daily",
      "pediatric": "0.01-0.02mg/kg daily",
      "elderly": "Lower doses, monitor closely"
    },
    "contraindications": [
      "Ventricular fibrillation",
      "Ventricular tachycardia",
      "Hypertrophic obstructive cardiomyopathy",
      "Wolff-Parkinson-White syndrome with atrial fibrillation"
    ],
    "side_effects": [
      "Nausea",
      "Vomiting",
      "Anorexia",
      "Visual disturbances (yellow-green vision)",
      "Cardiac arrhythmias",
      "Digoxin toxicity"
    ],
    "drug_interactions": [
      {
        "drug": "Amiodarone",
        "interaction": "Increased digoxin levels",
        "severity": "major"
      },
      {
        "drug": "Verapamil",
        "interaction": "Increased digoxin levels",
        "severity": "major"
      },
      {
        "drug": "Diuretics",
        "interaction": "Hypokalemia increases digoxin toxicity",
        "severity": "major"
      }
    ],
    "monitoring": [
      "Digoxin levels (target 0.5-0.9 ng/mL)",
      "Electrolytes (especially potassium)",
      "ECG",
      "Renal function"
    ],
    "pregnancy_category": "C",
    "breastfeeding": "Compatible",
    "sources": [
      {
        "type": "clinical_guideline",
        "title": "2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure",
        "journal": "Journal of the American College of Cardiology",
        "year": 2017,
        "url": "https://www.ahajournals.com/doi/10.1161/CIR.0000000000000509"
      }
    ]
  },
  {
    "drug_name": "Insulin",
    "generic_name": "insulin",
    "drug_class": "Hormone",
    "indications": [
      "Type 1 diabetes mellitus",
      "Type 2 diabetes mellitus (when oral agents fail)",
      "Diabetic ketoacidosis",
      "Hyperglycemic hyperosmolar state"
    ],
    "mechanism_of_action": "Regulates glucose metabolism by promoting glucose uptake into cells and inhibiting gluconeogenesis",
    "dosage": {
      "adult": "Variable based on blood glucose levels",
      "pediatric": "0.5-1.0 units/kg/day",
      "elderly": "Start with lower doses, frequent monitoring"
    },
    "contraindications": [
      "Hypoglycemia",
      "Hypersensitivity to insulin"
    ],
    "side_effects": [
      "Hypoglycemia",
      "Weight gain",
      "Injection site reactions",
      "Lipodystrophy",
      "Allergic reactions"
    ],
    "drug_interactions": [
      {
        "drug": "Alcohol",
        "interaction": "Increased hypoglycemia risk",
        "severity": "major"
      },
      {
        "drug": "Beta-blockers",
        "interaction": "Masked hypoglycemia symptoms",
        "severity": "major"
      },
      {
        "drug": "Corticosteroids",
        "interaction": "Increased insulin requirements",
        "severity": "moderate"
      }
    ],
    "monitoring": [
      "Blood glucose levels",
      "HbA1c",
      "Signs of hypoglycemia",
      "Weight"
    ],
    "pregnancy_category": "B",
    "breastfeeding": "Compatible",
    "sources": [
      {
        "type": "clinical_guideline",
        "title": "Standards of Medical Care in Diabetesâ€”2024",
        "journal": "Diabetes Care",
        "year": 2024,
        "url": "https://diabetesjournals.org/care/issue/47/Supplement_1"
      }
    ]
  },
  {
    "drug_name": "Morphine",
    "generic_name": "morphine sulfate",
    "drug_class": "Opioid analgesic",
    "indications": [
      "Severe pain",
      "Postoperative pain",
      "Cancer pain",
      "Acute myocardial infarction"
    ],
    "mechanism_of_action": "Binds to mu-opioid receptors in the central nervous system, producing analgesia and other effects",
    "dosage": {
      "adult": "5-15mg every 4 hours as needed",
      "pediatric": "0.1-0.2mg/kg every 4 hours",
      "elderly": "Start with lower doses, monitor closely"
    },
    "contraindications": [
      "Respiratory depression",
      "Acute or severe bronchial asthma",
      "Paralytic ileus",
      "Hypersensitivity to morphine"
    ],
    "side_effects": [
      "Respiratory depression",
      "Sedation",
      "Nausea",
      "Vomiting",
      "Constipation",
      "Pruritus",
      "Urinary retention"
    ],
    "drug_interactions": [
      {
        "drug": "Benzodiazepines",
        "interaction": "Increased respiratory depression",
        "severity": "major"
      },
      {
        "drug": "Alcohol",
        "interaction": "Increased CNS depression",
        "severity": "major"
      },
      {
        "drug": "MAO inhibitors",
        "interaction": "Serotonin syndrome risk",
        "severity": "major"
      }
    ],
    "monitoring": [
      "Respiratory rate",
      "Pain scores",
      "Level of consciousness",
      "Blood pressure"
    ],
    "pregnancy_category": "C",
    "breastfeeding": "Use with caution",
    "sources": [
      {
        "type": "clinical_guideline",
        "title": "Management of Opioid Therapy for Chronic Pain",
        "journal": "Journal of Pain",
        "year": 2016,
        "url": "https://www.jpain.org/article/S1526-5900(16)00012-4/fulltext"
      }
    ]
  },
  {
    "drug_name": "Aspirin",
    "generic_name": "acetylsalicylic acid",
    "drug_class": "Nonsteroidal anti-inflammatory drug (NSAID)",
    "indications": [
      "Cardiovascular disease prevention",
      "Acute coronary syndrome",
      "Stroke prevention",
      "Pain and inflammation",
      "Fever reduction"
    ],
    "mechanism_of_action": "Irreversibly inhibits cyclooxygenase (COX), preventing prostaglandin synthesis and platelet aggregation",
    "dosage": {
      "adult": "75-325mg daily for cardiovascular prevention",
      "pediatric": "10-15mg/kg every 4-6 hours (avoid in children <18 with viral infections)",
      "elderly": "Use lowest effective dose"
    },
    "contraindications": [
      "Active bleeding",
      "Severe liver disease",
      "Severe kidney disease",
      "Hypersensitivity to aspirin or NSAIDs",
      "Reye's syndrome risk in children"
    ],
    "side_effects": [
      "Gastrointestinal bleeding",
      "Peptic ulcer disease",
      "Nausea",
      "Vomiting",
      "Tinnitus",
      "Reye's syndrome (in children)"
    ],
    "drug_interactions": [
      {
        "drug": "Warfarin",
        "interaction": "Increased bleeding risk",
        "severity": "major"
      },
      {
        "drug": "Methotrexate",
        "interaction": "Increased methotrexate toxicity",
        "severity": "major"
      },
      {
        "drug": "ACE inhibitors",
        "interaction": "Reduced antihypertensive effect",
        "severity": "moderate"
      }
    ],
    "monitoring": [
      "Signs of bleeding",
      "Gastrointestinal symptoms",
      "Renal function"
    ],
    "pregnancy_category": "D (third trimester)",
    "breastfeeding": "Compatible in low doses",
    "sources": [
      {
        "type": "clinical_guideline",
        "title": "2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease",
        "journal": "Journal of the American College of Cardiology",
        "year": 2019,
        "url": "https://www.ahajournals.com/doi/10.1161/CIR.0000000000000678"
      }
    ]
  }
]
